Clinical Trials for Rindopepimut

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCNEU1216
10/02/2012
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.